Strategies to improve DEI in obstetrics and gynecology

May 06, 2022

Catherine Cansino, MD; Andrea Braden, MD; and Lisa Foglia, MD, spoke on how Metrics, wellness models, and management change are essential to advancing diversity, equity, and inclusion (DEI) in obstetrics and gynecology at the 2022 ACOG Annual Clinical & Scientific Meeting.

Making obstetrics and gynecology a more diverse and equitable environment

May 06, 2022

In this EdTalk, presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting, Lisa Foglia, MD; Andrea L. Braden, MD; and Catherine Cansino, MD, MPH, discuss strategies for improving diversity and equity within obstetrics and gynecology.

FDA warn public of risks, false results with noninvasive prenatal screening tests

April 27, 2022

The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.

Labor neuraxial analgesia and maternal morbidity

April 21, 2022

The use of labor neuraxial analgesia for vaginal delivery was associated with a 14% decrease in the risk of severe maternal morbidity (SMM), including postpartum hemorrhage (PPH), compared to vaginal delivery without neuraxial analgesia, according to a study published in JAMA Network Open.

SARS-CoV-2 infections and serious obstetric complications

April 20, 2022

A retrospective cohort study published in JAMA found that pregnant and postpartum women with SARS-CoV-2 infection were at a significantly increased risk of maternal mortality or serious morbidity from common obstetric complications.